15-minute Covid-19 immune status test launched in the UK and Ireland
July 26, 2021Sales and Marketing
Luas Diagnostics has launched a 15-minute test to determine immunity to Covid-19 post infection or vaccination. The product, which is …
Moderna jab approved for children aged 12-17 in the EU
July 26, 2021Sales and Marketing
The EU has approved the use of the Moderna COVID vaccine in children aged 12-17. Pfizer’s jab got the green …
Latest UK figures show COVID cases are falling
July 26, 2021Sales and Marketing
The number of people testing positive with COVID-19 is falling in the UK. The UK recorded 29,173 new cases on …
FDA approves Beximco Pharma’s muscle relaxant drug Baclofen
July 26, 2021Sales and Marketing
Beximco Pharma has received FDA approval for Baclofen (10 and 20 mg tablets). Baclofen is a muscle relaxant drug indicated …
New NICE guideline on C. difficile rejects metronidazole prescription
July 23, 2021Medical Communications
NICE has published a new guideline covering C. difficile infection, the latest in the series of antimicrobial prescribing guidelines which …
Eight-week vaccine gap with Pfizer is best for antibodies
July 23, 2021Medical Communications
UK researchers have found an eight-week gap between first and second doses of the Pfizer-BioNTech appears to be the “sweet …
Expansion for first FDA-approved video game for ADHD treatment
July 23, 2021Medical Communications, Research and Development ADHD, FDA, US, digital therapeutics, technology
Akili Interactive has announced the expansion of its prescription video game treatment, EndeavorRx, with the addition of new gaming features …
Biogen pens open letter to Alzheimer’s community
July 23, 2021Medical Communications
In the wake of the controversial approval of Biogen’s Alzheimer’s drug, Aduhelm, the company has penned an open letter to …
Parents warned as child respiratory illness on the rise this summer
July 23, 2021Medical Communications
Parents are being warned to be on the lookout for signs of a common childhood respiratory illness, RSV, as cases …
Two shots of Pfizer or AstraZeneca vaccine are effective against Delta variant
July 22, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
A new study has shown that two shots of either Pfizer or AstraZeneca’s COVID-19 vaccine are nearly as effective against …
Bayer/MSD heart failure drug gains EC approval
July 22, 2021The European Commission (EC) has approved MSD and Bayer’s Verquvo (vericiguat) for the treatment of symptomatic chronic heart failure in …
China rejects a second WHO probe into COVID outbreak origin
July 22, 2021COVID-19, China
China has rejected WHO plans for a second investigation into the origin of the coronavirus pandemic, which includes the hypothesis …
Roche discussing potential Alzheimer’s treatment with FDA
July 22, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Roche is discussing its potential treatment, gantenerumab, for Alzheimer’s disease with the FDA as clinical trials proceed. Chief Executive Severin …
NICE approves treatment for rare bile duct cancer
July 22, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
NICE has approved Pemigatinib (Pemazyre) as first treatment for people with a rare form of bile duct cancer (cholangiocarcinoma). Pemigatinib, …
$100 million expansion planned for Catalent’s Italian vaccine plant
July 21, 2021Manufacturing and Production, Research and Development
Contract drug manufacturer, Catalent, has announced its $100 million expansion plans for its site in Agnani, Italy, where it is …
Former FDA adviser calls for further investigation into Alzheimer’s drug
July 21, 2021Research and Development
A former FDA advisor who resigned after the controversial approval of Biogen’s Alzheimer’s drug has called for a wider probe …
Exscientia and Apeiron announce joint oncology venture
July 21, 2021Research and Development
AI pharmatech company, Exscientia, has announced a collaboration with Shanghai-based GT Apeiron Therapeutics, which will focus on oncology. The strategic …
J&J ‘one shot’ vaccine ineffective against Delta variant, study finds
July 21, 2021Medical Communications, Research and Development
A new study posted online on Tuesday, has found that Johnson & Johnson’s COVID-19 vaccine is much less effective against …
More than 13,000 women report period changes after COVID vaccine
July 21, 2021Research and Development COVID, Vaccine, menstruation, periods
The number of women who have reported changes to their period to the MHRA after having the COVID vaccine has …
Bial and Medis to enter partnership on CNS treatments
July 20, 2021Manufacturing and Production, Sales and Marketing
BIAL and Medis have entered into an exclusive partnership on two of Bial’s proprietary drugs: its Parkinson’s treatment Ongentys (opicapone) …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
